These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7331998)

  • 21. [Clinical aspects of continuous ambulatory peritoneal dialysis in diabetics].
    Rottembourg J; Issad B; Allouache M; Ruotolo C; Deray G; Baumelou A; Kahn JF; Jacobs C
    Nephrologie; 1988; 9(5):227-32. PubMed ID: 3063989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Continuous ambulatory peritoneal dialysis in diabetic patients].
    Stojimrović B; Nesić V
    Srp Arh Celok Lek; 1998; 126(7-8):277-82. PubMed ID: 9863395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous ambulatory peritoneal dialysis in type II diabetics.
    Wei SS; Lee GS; Woo KT; Lim CH
    Ann Acad Med Singap; 1993 Jul; 22(4):629-33. PubMed ID: 8257073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous ambulatory peritoneal dialysis in insulin-dependent diabetic patients: a 40-month experience.
    Rottembourg J; el Shahat Y; Agrafiotis A; Thuillier Y; de Groc F; Jacobs C; Legrain M
    Kidney Int; 1983 Jan; 23(1):40-5. PubMed ID: 6339788
    [No Abstract]   [Full Text] [Related]  

  • 25. Patient and technique survival for blind and sighted diabetics on continuous ambulatory peritoneal dialysis: a ten-year analysis.
    Chandran PK; Lane T; Flynn CT
    Int J Artif Organs; 1991 May; 14(5):262-8. PubMed ID: 1864649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is peritoneal dialysis the preferred modality in the diabetic patient?
    Kraus MA; Hamburger RJ
    Adv Perit Dial; 1996; 12():89-92. PubMed ID: 8865879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
    Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
    Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory peritoneal dialysis in a Mexican PD center.
    Sanchez AR; Madonia C; Rascon-Pacheco RA
    Kidney Int Suppl; 2008 Apr; (108):S76-80. PubMed ID: 18379553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three and a half years experience with CAPD using the Beta Cap technique.
    Mavichak V; Moriarty MV; Cameron EC; Reeve CE; Ballon HS; Lauener RW; Price JD
    Trans Am Soc Artif Intern Organs; 1982; 28():253-8. PubMed ID: 7164246
    [No Abstract]   [Full Text] [Related]  

  • 30. Continuous ambulatory peritoneal dialysis (CAPD): eight years after its introduction.
    Sombolos K; Oreopoulos DG
    Life Support Syst; 1985; 3 Suppl 1():96-106. PubMed ID: 3916636
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of patient and technique survival in continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis: a multicenter study.
    Serkes KD; Blagg CR; Nolph KD; Vonesh EF; Shapiro F
    Perit Dial Int; 1990; 10(1):15-9. PubMed ID: 2085575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is continuous ambulatory peritoneal dialysis the best dialysis choice for insulin dependent diabetics?
    Rottembourg J; de Groc F; Poignet JL; Legrain M
    Proc Eur Dial Transplant Assoc; 1983; 19():215-20. PubMed ID: 6348737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Continuous ambulatory peritoneal dialysis treatment and blood glucose control in diabetics with end-stage diabetic nephropathy].
    Li GW; Liu J; Chen L
    Zhonghua Nei Ke Za Zhi; 1989 Jun; 28(6):360-3, 382. PubMed ID: 2684575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Which dialysis method should be proposed to type 2 diabetics?].
    Ryckelynck JP
    Nephrologie; 2000; 21(4):161-2. PubMed ID: 10976430
    [No Abstract]   [Full Text] [Related]  

  • 35. CAPD and transplantation in diabetics.
    Passlick J; Grabensee B
    Clin Nephrol; 1988; 30 Suppl 1():S18-23. PubMed ID: 3052957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variability of peritoneal protein loss in diabetic and nondiabetic patients on continuous ambulatory peritoneal dialysis.
    Spaia S; Christidou F; Pangidis P; Tsoulkas T; Pazarloglou M; Pappa A; Vayonas G
    Perit Dial Int; 1993; 13 Suppl 2():S242-4. PubMed ID: 8399578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in fluid and solute transport between diabetic and nondiabetic patients at the onset of CAPD.
    Serlie MJ; Struijk DG; de Blok K; Krediet RT
    Adv Perit Dial; 1997; 13():29-32. PubMed ID: 9360646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transfer of native insulin through the peritoneal membrane during CAPD in non-diabetic and diabetic patients.
    Ersoy FF; Karayalcin U; Karayalcin B; Sapan M; Bozcuk H; Süleymanlar G; Yakupoglu G
    Adv Perit Dial; 1995; 11():119-22. PubMed ID: 8534683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of insulin delivery route on lipoproteins in type I diabetic patients on CAPD.
    Nevalainen PI; Lahtela JT; Mustonen J; Taskinen MR; Pasternack A
    Perit Dial Int; 1999; 19(2):148-53. PubMed ID: 10357186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The treatment of diabetic end-stage renal disease with peritoneal dialysis.
    Feriani M; Dell'Aquila R; La Greca G
    Nephrol Dial Transplant; 1998; 13 Suppl 8():53-6. PubMed ID: 9870427
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.